Examine the heart function of elite athletes and heart failure patients utilizing a novel catheter system.
The primary objective of this research protocol is to advance the understanding of cardiopulmonary and right ventricular (RV) performance among individuals with cardiomyopathy (heart failure with reduced ejection fraction [HFrEF], heart failure with preserved ejection fraction [HFpEF]), as well as athletes engaging in endurance/prolonged exercise, who are at a high risk of an acquired cardiomyopathy during/following completion of an endurance event.
Either elite endurance athletes or heart failure patients. Adult population
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
University of Colorado Hospital
Protocol Number: 19-1141
More information available at ClinicalTrials.gov: NCT04147299
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers